AVXL: Anavex Life Sciences Corp insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 0 sales totaling - in the last 180 days.
Activist and 5% holders
| Filed | What | Holder | Stake | Change | Filing |
|---|---|---|---|---|---|
| 2026-07-31 | New 13G stake | Vanguard Capital Management | 5.03% | SEC |
Institutional ownership (Q2 2026)
180 institutions reported holding $95.14M of Anavex Life Sciences Corp on Form 13F (190 the quarter before). 24 opened a new position and 33 sold out. Shares held by institutions: -8%.
| Largest holders | Shares | Value |
|---|---|---|
| BlackRock, Inc. | 8,055,628 | $20.86M |
| VANGUARD CAPITAL MANAGEMENT LLC | 4,054,589 | $10.50M |
| TWO SIGMA INVESTMENTS, LP | 3,046,538 | $7.89M |
| GEODE CAPITAL MANAGEMENT, LLC | 2,407,473 | $6.24M |
| STATE STREET CORP | 1,922,770 | $4.98M |
| FEDERATED HERMES, INC. | 1,071,809 | $2.78M |
| AQR CAPITAL MANAGEMENT LLC | 963,014 | $2.49M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 948,633 | $2.46M |
| Summit Financial, LLC | 909,430 | $2.36M |
| GOLDMAN SACHS GROUP INC | 890,634 | $2.31M |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.